{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:08:13Z","timestamp":1790204893983,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PI 13\/02269"],"award-info":[{"award-number":["PI 13\/02269"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["2010-17226"],"award-info":[{"award-number":["2010-17226"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["2016-77894-R"],"award-info":[{"award-number":["2016-77894-R"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.coviro.2019.05.010","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T06:21:24Z","timestamp":1561616484000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Elite controllers and lessons learned for HIV-1 cure"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-9584","authenticated-orcid":false,"given":"Cecilio","family":"Lopez-Galindez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pernas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepcion","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Lorenzo-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2019.05.010_bib0005","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the latent reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2019.05.010_bib0010","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1074\/jbc.RA118.005185","article-title":"Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation","volume":"294","author":"Beliakova-Bethell","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2019.05.010_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2019.05.010_bib0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12879-017-2683-3","article-title":"Landscape review of current HIV \u2018kick and kill\u2019 cure research - some kicking, not enough killing","volume":"17","author":"Thorlund","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.coviro.2019.05.010_bib0025","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2019.05.010_bib0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.05.010_bib0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41577-018-0085-4","article-title":"Functional cure of HIV: the scale of the challenge","volume":"19","author":"Davenport","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2019.02.005","article-title":"Adeno-associated virus delivery of anti-HIV monoclonal antibodies can drive long-term virologic suppression","volume":"50","author":"Martinez-Navio","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2019.05.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011079","article-title":"Host and viral genetic correlates of clinical definitions of HIV-1 disease progression","volume":"5","author":"Casado","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2019.05.010_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/COH.0b013e328345a328","article-title":"Elite controllers as a model of functional cure","volume":"6","author":"Autran","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2019.05.010_bib0055","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1016\/j.vaccine.2017.08.070","article-title":"HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV","volume":"35","author":"Sundaramurthi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2019.05.010_bib0060","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The major genetic determinants of HIV-1 control affect HLA class I peptide presentation","volume":"330","author":"Pereyra","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.05.010_bib0065","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/ciw833","article-title":"HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers","volume":"64","author":"Dominguez-Molina","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2019.05.010_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005339","article-title":"Estimating the respective contributions of human and viral genetic variation to HIV control","volume":"13","author":"Bartha","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007222","article-title":"HIV control: is getting there the same as staying there?","volume":"14","author":"Goulder","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.05.010_bib0080","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3389\/fimmu.2018.02876","article-title":"Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1","volume":"9","author":"Colomer-Lluch","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1099\/jgv.0.001026","article-title":"Novel host restriction factors implicated in HIV-1 replication","volume":"99","author":"Ghimire","year":"2018","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0090","article-title":"HIV controllers exhibit enhanced frequencies of major histocompatibility complex class II tetramer(+) Gag-specific CD4(+) T cells in chronic clade C HIV-1 infection","volume":"91","author":"Laher","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0095","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/JVI.01805-17","article-title":"Factors leading to the loss of natural elite control of HIV-1 infection","volume":"92","author":"Pernas","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0100","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3389\/fimmu.2018.01576","article-title":"Plasmatic levels of IL-18, IP-10, and activated CD8(+) T cells are potential biomarkers to identify HIV-1 elite controllers with a true functional cure profile","volume":"9","author":"Cortes","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.2422","article-title":"Protective HIV-specific CD8+ T cells evade Treg cell suppression","volume":"17","author":"Elahi","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2019.05.010_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.antiviral.2009.08.007","article-title":"Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?","volume":"85","author":"Blankson","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.coviro.2019.05.010_bib0115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00700-17","article-title":"HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV","volume":"91","author":"Madhavi","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ebiom.2017.05.029","article-title":"HIV-specific B cell frequency correlates with neutralization breadth in patients naturally controlling HIV-infection","volume":"21","author":"Rouers","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2019.05.010_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193773","article-title":"Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors","volume":"13","author":"Gonzalez","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2019.05.010_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2017.07.007","article-title":"Neutralizing antibodies against a specific human immunodeficiency virus gp41 epitope are associated with long-term non-progressor status","volume":"22","author":"Lucar","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2019.05.010_bib0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01690-18","article-title":"HIV controllers have low inflammation associated with a strong HIV-specific immune response in blood","volume":"93","author":"Hocini","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0140","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/JVI.00419-16","article-title":"Long-term spontaneous control of HIV-1 is related to low frequency of infected cells and inefficient viral reactivation","volume":"90","author":"Noel","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0145","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1126\/science.270.5238.988","article-title":"Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients","volume":"270","author":"Deacon","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.05.010_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2009.05.022","article-title":"A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs","volume":"391","author":"Sandonis","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2019.05.010_bib0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.05.010_bib0160","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01050-17","article-title":"Effects of mutations on replicative fitness and major histocompatibility complex class I binding affinity are among the determinants underlying cytotoxic-T-lymphocyte escape of HIV-1 Gag epitopes","volume":"8","author":"Du","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2019.05.010_bib0165","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1128\/JVI.00335-13","article-title":"Replication fitness of multiple nonnucleoside reverse transcriptase-resistant HIV-1 variants in the presence of etravirine measured by 454 deep sequencing","volume":"87","author":"Brumme","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000377","article-title":"Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics","volume":"5","author":"Lassen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.05.010_bib0175","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00094-19","article-title":"A highly unusual V1 region of Env in an elite controller of HIV infection","volume":"93","author":"Silver","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0180","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02338-17","article-title":"Viral characteristics associated with the clinical nonprogressor phenotype are inherited by viruses from a cluster of HIV-1 elite controllers","volume":"9","author":"Casado","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2019.05.010_bib0185","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JVI.02165-06","article-title":"Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors","volume":"81","author":"Blankson","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0190","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1128\/JVI.03380-13","article-title":"HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice","volume":"88","author":"Salgado","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0195","doi-asserted-by":"crossref","first-page":"122795","DOI":"10.1172\/jci.insight.122795","article-title":"Long-term remission despite clonal expansion of replication-competent HIV-1 isolates","volume":"3","author":"Veenhuis","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2019.05.010_bib0200","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/COH.0b013e3283454cf5","article-title":"HIV-1 replicative fitness in elite controllers","volume":"6","author":"Lobritz","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2019.05.010_bib0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ebiom.2017.12.003","article-title":"What is the most important for elite control: genetic background of patient, genetic background of partner, both or neither? Description of complete natural history within a couple of MSM","volume":"27","author":"Bendenoun","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2019.05.010_bib0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ebiom.2017.01.034","article-title":"Factors associated with the control of viral replication and virologic breakthrough in a recently infected HIV-1 controller","volume":"16","author":"Walker-Sperling","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2019.05.010_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031928","article-title":"Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller","volume":"7","author":"Pernas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2019.05.010_bib0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2011.07.007","article-title":"HIV controllers: a multifactorial phenotype of spontaneous viral suppression","volume":"141","author":"Theze","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0225","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/jvi.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase","volume":"69","author":"Mansky","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00249-018-1282-6","article-title":"Quasispecies and virus","volume":"47","author":"Domingo","year":"2018","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.coviro.2019.05.010_bib0235","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/JVI.73.4.2745-2751.1999","article-title":"Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events","volume":"73","author":"Yuste","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11262-018-1571-2","article-title":"The degree of HIV-1 amino acid variability is strictly related to different disease progression rates","volume":"54","author":"Scutari","year":"2018","journal-title":"Virus Genes"},{"key":"10.1016\/j.coviro.2019.05.010_bib0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12977-017-0354-5","article-title":"Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers","volume":"14","author":"de Azevedo","year":"2017","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.05.010_bib0250","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1128\/JVI.80.10.4758-4770.2006","article-title":"Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy","volume":"80","author":"Bailey","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.05.010_bib0255","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1089\/aid.2007.0074","article-title":"Plasma viral load threshold for sustaining intrahost HIV type 1 evolution","volume":"23","author":"Bello","year":"2007","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625719300264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625719300264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:19:44Z","timestamp":1783631984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625719300264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":51,"alternative-id":["S1879625719300264"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2019.05.010","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elite controllers and lessons learned for HIV-1 cure","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2019.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}